Transkutanes Compress®-Implantat zur Rehabilitation nach Extremitätenamputation

Translated title of the contribution: The Compress® transcutaneous implant for rehabilitation following limb amputation

R. L. McGough, M. A. Goodman, R Randall, J. A. Forsberg, B. K. Potter, B. Lindsey

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Amputation is an unfortunate outcome of a variety of orthopedic conditions. Many amputees can be functionally fitted with conventional suspension sockets. A substantial subset, however, fails this conventional treatment and is unable to function. In Europe, an alternative to socket-based prostheses has been available for 25 years. Patients there who are unable to functionally use socket-based prostheses have been offered the possibility for transcutaneous osseointegration. With this technology, the prosthetic limb can be rigidly attached to the residual bone, and the socket is eliminated, in many cases enabling improved function and patient satisfaction. In the United States, regulatory barriers have greatly limited the adoption and acceptance of transdermal osseointegration. The Compress® device was developed as an alternate means of fixation for massive endoprostheses, such as distal femoral replacements. A uniquely designed prosthesis is rigidly anchored to the end of the cortical bone and is then subjected to a large axial stress. The bone then grows avidly into the device, providing permanent osseointegration. We have recently adopted this device for transcutaneous use. These procedures have been performed in the United States on a custom regulatory basis. Results of this have been encouraging, and we are planning to begin a regulatory trial in the near future.

Original languageGerman
Pages (from-to)300-305
Number of pages6
JournalUnfallchirurg
Volume120
Issue number4
DOIs
StatePublished - Apr 1 2017
Externally publishedYes

Fingerprint

Osseointegration
Amputation
Prostheses and Implants
Rehabilitation
Extremities
Equipment and Supplies
Bone and Bones
Amputees
Thigh
Patient Satisfaction
Orthopedics
Suspensions
Technology
Therapeutics

Keywords

  • Artificial limbs
  • Femur
  • Humerus
  • Prostheses and implants
  • Quality of life

ASJC Scopus subject areas

  • Surgery
  • Emergency Medicine
  • Orthopedics and Sports Medicine

Cite this

McGough, R. L., Goodman, M. A., Randall, R., Forsberg, J. A., Potter, B. K., & Lindsey, B. (2017). Transkutanes Compress®-Implantat zur Rehabilitation nach Extremitätenamputation. Unfallchirurg, 120(4), 300-305. https://doi.org/10.1007/s00113-017-0339-9

Transkutanes Compress®-Implantat zur Rehabilitation nach Extremitätenamputation. / McGough, R. L.; Goodman, M. A.; Randall, R; Forsberg, J. A.; Potter, B. K.; Lindsey, B.

In: Unfallchirurg, Vol. 120, No. 4, 01.04.2017, p. 300-305.

Research output: Contribution to journalArticle

McGough, RL, Goodman, MA, Randall, R, Forsberg, JA, Potter, BK & Lindsey, B 2017, 'Transkutanes Compress®-Implantat zur Rehabilitation nach Extremitätenamputation', Unfallchirurg, vol. 120, no. 4, pp. 300-305. https://doi.org/10.1007/s00113-017-0339-9
McGough, R. L. ; Goodman, M. A. ; Randall, R ; Forsberg, J. A. ; Potter, B. K. ; Lindsey, B. / Transkutanes Compress®-Implantat zur Rehabilitation nach Extremitätenamputation. In: Unfallchirurg. 2017 ; Vol. 120, No. 4. pp. 300-305.
@article{0cc2da486e02492eaebf334783b14725,
title = "Transkutanes Compress{\circledR}-Implantat zur Rehabilitation nach Extremit{\"a}tenamputation",
abstract = "Amputation is an unfortunate outcome of a variety of orthopedic conditions. Many amputees can be functionally fitted with conventional suspension sockets. A substantial subset, however, fails this conventional treatment and is unable to function. In Europe, an alternative to socket-based prostheses has been available for 25 years. Patients there who are unable to functionally use socket-based prostheses have been offered the possibility for transcutaneous osseointegration. With this technology, the prosthetic limb can be rigidly attached to the residual bone, and the socket is eliminated, in many cases enabling improved function and patient satisfaction. In the United States, regulatory barriers have greatly limited the adoption and acceptance of transdermal osseointegration. The Compress{\circledR} device was developed as an alternate means of fixation for massive endoprostheses, such as distal femoral replacements. A uniquely designed prosthesis is rigidly anchored to the end of the cortical bone and is then subjected to a large axial stress. The bone then grows avidly into the device, providing permanent osseointegration. We have recently adopted this device for transcutaneous use. These procedures have been performed in the United States on a custom regulatory basis. Results of this have been encouraging, and we are planning to begin a regulatory trial in the near future.",
keywords = "Artificial limbs, Femur, Humerus, Prostheses and implants, Quality of life",
author = "McGough, {R. L.} and Goodman, {M. A.} and R Randall and Forsberg, {J. A.} and Potter, {B. K.} and B. Lindsey",
year = "2017",
month = "4",
day = "1",
doi = "10.1007/s00113-017-0339-9",
language = "German",
volume = "120",
pages = "300--305",
journal = "Der Unfallchirurg",
issn = "0177-5537",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Transkutanes Compress®-Implantat zur Rehabilitation nach Extremitätenamputation

AU - McGough, R. L.

AU - Goodman, M. A.

AU - Randall, R

AU - Forsberg, J. A.

AU - Potter, B. K.

AU - Lindsey, B.

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Amputation is an unfortunate outcome of a variety of orthopedic conditions. Many amputees can be functionally fitted with conventional suspension sockets. A substantial subset, however, fails this conventional treatment and is unable to function. In Europe, an alternative to socket-based prostheses has been available for 25 years. Patients there who are unable to functionally use socket-based prostheses have been offered the possibility for transcutaneous osseointegration. With this technology, the prosthetic limb can be rigidly attached to the residual bone, and the socket is eliminated, in many cases enabling improved function and patient satisfaction. In the United States, regulatory barriers have greatly limited the adoption and acceptance of transdermal osseointegration. The Compress® device was developed as an alternate means of fixation for massive endoprostheses, such as distal femoral replacements. A uniquely designed prosthesis is rigidly anchored to the end of the cortical bone and is then subjected to a large axial stress. The bone then grows avidly into the device, providing permanent osseointegration. We have recently adopted this device for transcutaneous use. These procedures have been performed in the United States on a custom regulatory basis. Results of this have been encouraging, and we are planning to begin a regulatory trial in the near future.

AB - Amputation is an unfortunate outcome of a variety of orthopedic conditions. Many amputees can be functionally fitted with conventional suspension sockets. A substantial subset, however, fails this conventional treatment and is unable to function. In Europe, an alternative to socket-based prostheses has been available for 25 years. Patients there who are unable to functionally use socket-based prostheses have been offered the possibility for transcutaneous osseointegration. With this technology, the prosthetic limb can be rigidly attached to the residual bone, and the socket is eliminated, in many cases enabling improved function and patient satisfaction. In the United States, regulatory barriers have greatly limited the adoption and acceptance of transdermal osseointegration. The Compress® device was developed as an alternate means of fixation for massive endoprostheses, such as distal femoral replacements. A uniquely designed prosthesis is rigidly anchored to the end of the cortical bone and is then subjected to a large axial stress. The bone then grows avidly into the device, providing permanent osseointegration. We have recently adopted this device for transcutaneous use. These procedures have been performed in the United States on a custom regulatory basis. Results of this have been encouraging, and we are planning to begin a regulatory trial in the near future.

KW - Artificial limbs

KW - Femur

KW - Humerus

KW - Prostheses and implants

KW - Quality of life

UR - http://www.scopus.com/inward/record.url?scp=85014632392&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014632392&partnerID=8YFLogxK

U2 - 10.1007/s00113-017-0339-9

DO - 10.1007/s00113-017-0339-9

M3 - Article

C2 - 28275847

AN - SCOPUS:85014632392

VL - 120

SP - 300

EP - 305

JO - Der Unfallchirurg

JF - Der Unfallchirurg

SN - 0177-5537

IS - 4

ER -